TY - JOUR
T1 - Expanding the manufacturing capacity for cell and gene therapies
T2 - an interview with Julie G Allickson
AU - Allickson, Julie G.
N1 - Publisher Copyright:
© 2023 Future Medicine Ltd.
PY - 2023/5/1
Y1 - 2023/5/1
N2 - Julie G Allickson, PhD, is the Michael S and Mary Sue Shannon Family Director of Mayo Clinic's Center for Regenerative Biotherapeutics at Mayo Clinic (Minnesota, Florida and Arizona) and the Otto Bremer Trust Director, Biomanufacturing and Product Development, Center for Regenerative Biotherapeutics. With over 25 years of experience in regenerative medicine, cellular therapies and regulatory affairs, Dr Allickson leads the center as it pivots toward biomanufacturing, ensuring that discoveries are successful for clinical translation and eventually commercialization. The center is in the process of building their industry experienced team on all pillars of biomanufacturing to support clinical and principal investigators at the Mayo Clinic.
AB - Julie G Allickson, PhD, is the Michael S and Mary Sue Shannon Family Director of Mayo Clinic's Center for Regenerative Biotherapeutics at Mayo Clinic (Minnesota, Florida and Arizona) and the Otto Bremer Trust Director, Biomanufacturing and Product Development, Center for Regenerative Biotherapeutics. With over 25 years of experience in regenerative medicine, cellular therapies and regulatory affairs, Dr Allickson leads the center as it pivots toward biomanufacturing, ensuring that discoveries are successful for clinical translation and eventually commercialization. The center is in the process of building their industry experienced team on all pillars of biomanufacturing to support clinical and principal investigators at the Mayo Clinic.
KW - cell therapy
KW - gene therapy
KW - manufacturing capacity
KW - workforce development
UR - http://www.scopus.com/inward/record.url?scp=85159738824&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85159738824&partnerID=8YFLogxK
U2 - 10.2217/rme-2023-0057
DO - 10.2217/rme-2023-0057
M3 - Review article
C2 - 37165963
AN - SCOPUS:85159738824
SN - 1746-0751
VL - 18
SP - 373
EP - 375
JO - Regenerative Medicine
JF - Regenerative Medicine
IS - 5
ER -